Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
CTI BioPharma Corporation | CTIC | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
9.09 | 9.09 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
06/7/2023 | 15:15 | EDGAR2 | Form 15-12G - Securities registration termination [Section.. |
29/6/2023 | 23:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
28/6/2023 | 17:26 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
28/6/2023 | 12:51 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
24/6/2023 | 05:51 | PRNUS | Sobi successfully completes tender offer for all outstanding.. |
24/6/2023 | 05:49 | PRNUS | Sobi successfully completes tender offer for all outstanding.. |
30/5/2023 | 15:35 | PRNUS | CTI BioPharma Announces Cancellation of its 2023 Annual.. |
10/5/2023 | 00:06 | PRNUS | Sobi to Acquire CTI BioPharma |
04/5/2023 | 18:55 | PRNUS | CTI BioPharma Announces Inducement Grants Under Nasdaq.. |
02/5/2023 | 15:35 | PRNUS | CTI BioPharma Announces Inducement Grants Under Nasdaq.. |
01/5/2023 | 15:46 | PRNUS | CTI BioPharma To Report First Quarter 2023 Financial Results.. |
01/5/2023 | 06:03 | PRNUS | CTI BioPharma Announces Two Abstracts Accepted for.. |